Literature DB >> 10048088

Breast tumors with myofibroblastic differentiation: clinico-pathological observations in myofibroblastoma and myofibrosarcoma.

A Gocht1, H C Bösmüller, R Bässler, F A Tavassoli, F Moinfar, D Katenkamp, K Schirrmacher, P Lüders, W Saeger.   

Abstract

This report describes the clinico-pathological features of myofibroblastic tumors of the breast in six patients. Four women and one man presented with a benign myofibroblastoma. The sixth patient was a woman with myofibrosarcoma. All myofibroblastomas were composed of a fascicular arrangement of spindle cells embedded in dense bundles of collagen. Tumors differed with respect to their proportion of neoplastic cells and collagenous stroma as well as cellular pleomorphism. Based on this variation, the tumors could be subclassified as classic, collagenized, epithelioid and cellular myofibroblastoma. Immunohistological staining confirmed myofibroblastic differentiation by strong expression of either desmin or smooth muscle actin with coexpression of vimentin. In addition, numerous cells reacted with antibodies to CD68. Proliferative activity was rather low in the myofibroblastoma with an average of 0-2 mitotic figures per 10 HPF. DNA cytometric analysis was performed in two cases and showed diploid stem lines with minor S-phase fractions (1% and 3%). In the myofibrosarcoma, cells contained pleomorphic nuclei with some giant cells and numerous mitotic figures (6-7/10 HPF) and had infiltrating margins that were apparent even grossly. Immunohistochemically, tumor cells strongly expressed vimentin, smooth muscle actin and fibronectin. Ultrastructurally, neoplastic cells met the criteria of myofibroblasts, i.e. contained abundant intermediate filaments and myofilament bundles with focal densities as well as fibronexus junctions. DNA cytometric analysis exhibited again a diploid stemline but marked proliferative activity was present as indicated by an S-phase fraction of 20%. In conclusion, in benign myofibroblastoma there may be some cellular pleomorphism but mitotic activity is always low. The malignant counterpart, myofibrosarcoma, is characterized by marked cellular pleomorphism, infiltrating margins and high mitotic rate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048088     DOI: 10.1016/S0344-0338(99)80087-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  Breast sarcoma showing myofibroblastic differentiation.

Authors:  Ksenija Lucin; Elvira Mustać; Nives Jonjić
Journal:  Virchows Arch       Date:  2003-07-03       Impact factor: 4.064

2.  Epithelioid myofibroblastoma of the breast: A case report and review of the literature.

Authors:  Takahiro Inaishi; Takahiko Sakuma; Tomoki Fukuoka; Shu Ichihara
Journal:  Int J Surg Case Rep       Date:  2022-07-02

Review 3.  Myofibrosarcoma.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2004-06-02       Impact factor: 4.064

4.  [Syntopical and synchronous leiomyosarcoma and papillary carcinoma of the female breast].

Authors:  W Saeger
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

5.  Myofibroblastoma of the male breast: a rare entity with radiologic-pathologic correlation.

Authors:  John D Comer; Xiaoyan Cui; Carolyn Sharyn Eisen; Genevieve Abbey; Elizabeth Kagan Arleo
Journal:  Clin Imaging       Date:  2016-11-30       Impact factor: 1.605

6.  Breast spindle cell tumours: about eight cases.

Authors:  Howayda S Abd el-All
Journal:  Diagn Pathol       Date:  2006-07-22       Impact factor: 2.644

7.  Low-grade myofibroblastic sarcoma arising in fibroadenoma of the breast-A case report.

Authors:  Na-Hye Myong; Jun-Won Min
Journal:  Diagn Pathol       Date:  2016-03-25       Impact factor: 2.644

8.  Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals.

Authors:  Seul Ki Kim; Ji Sun Lee; Su Been Hong; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

Review 9.  Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.

Authors:  G Magro; L Salvatorelli; L Puzzo; E Piombino; G Bartoloni; G Broggi; G M Vecchio
Journal:  Pathologica       Date:  2019-12

10.  Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.

Authors:  Jane O'Bryan; Carolyn Wolf-Gould; Yoshiro Matsuo
Journal:  Transgend Health       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.